CMAS and breast cancer: In the blue module, Cdc34 codes for a ubiquitin-conjugating enzyme that regulates cell cycle progression, while Cmas encodes a key enzyme (cytidine monophosphate N-acetylneuraminic acid synthetase) in the sialylation pathway that enhances invasion of breast cancer cells [15].